![Eli Hazum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eli Hazum
Technik-/Wissenschafts-/F&E-Leiter bei
Medica Venture Partners
Profil
Eli Hazum is currently General Partner, Partner, and CSO at Medica Venture Partners since 1995.
Former roles include Chief Executive Officer at Regentis Biomaterials Ltd. from 2021 to 2025, Chief Executive Officer at Ester Neurosciences Ltd., Chief Executive Officer and Director at Collgard Biopharmaceuticals Ltd., Director and Chief Technology Officer at PRF Technologies Ltd. from 2020 to 2025, Vice President-Research & Development at Peptor Ltd, Principal at Biotechnology General (Israel) Ltd., Head-Receptor Research & Metabolic Diseases at Research Triangle Foundation, and Head-Receptor Research & Metabolic Diseases at Glaxo, Inc. from 1988 to 1992.
Education includes undergraduate and graduate degrees from Tel-Aviv University, a doctorate from Weizmann Institute of Science conferred in 1978, and an MBA from Humberside University.
Aktive Positionen von Eli Hazum
| Unternehmen | Position | Beginn |
|---|---|---|
Medica Venture Partners
 Medica Venture Partners Investment ManagersFinance Medica Ventures Partners invests in public and private companies located in Israel, Europe and the United States. The firm focuses on health care and life science technologies from medical devices to pharmaceuticals, biotech and genomics sectors. It provides financing for seed and early stage capital requirements. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
Ehemalige bekannte Positionen von Eli Hazum
| Unternehmen | Position | Ende |
|---|---|---|
| REGENTIS BIOMATERIALS LTD. | Vorstandsvorsitzender | 31.12.2025 |
| PRF TECHNOLOGIES LTD. | Vorstandsvorsitzender | 23.11.2020 |
Glaxo, Inc. | Corporate Officer/Principal | 01.01.1992 |
Research Triangle Foundation
 Research Triangle Foundation Miscellaneous Commercial ServicesCommercial Services Povides grants and creative services to support biotech companies | Corporate Officer/Principal | - |
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Eli Hazum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Peptor Ltd
 Peptor Ltd Pharmaceuticals: MajorHealth Technology Develops products to treat autoimmune diseases | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medica Venture Partners
Medica Venture Partners Investment ManagersFinance Medica Ventures Partners invests in public and private companies located in Israel, Europe and the United States. The firm focuses on health care and life science technologies from medical devices to pharmaceuticals, biotech and genomics sectors. It provides financing for seed and early stage capital requirements. | Finance |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Triangle Foundation
Research Triangle Foundation Miscellaneous Commercial ServicesCommercial Services Povides grants and creative services to support biotech companies | Commercial Services |
Ester Neurosciences Ltd.
 Ester Neurosciences Ltd. Medical SpecialtiesHealth Technology Provides discovery and development of novel therapeutic products for the treatment of neurological disorders | Health Technology |
Collgard Biopharmaceuticals Ltd.
 Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures tissue therapeutics | Health Technology |
Glaxo, Inc. | |
Regentis Biomaterials Ltd.
 Regentis Biomaterials Ltd. BiotechnologyHealth Technology Develops proprietary hydrogels for tissue regeneration | Health Technology |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
PainReform Ltd.
 PainReform Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for pain treatment | Health Technology |
Humberside University
 Humberside University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
